
INDV P/E Ratio
P/E Ratio as of Feb 2, 2026: 34.85
Average34.23
Median34.48
Minimum32.40
Maximum36.09
34.85
0.72 (2.02%)past month
The P/E ratio for INDV is 34.85 as of Feb 2, 2026. This represents a decrease of -21,881.25% compared to its 12-month average P/E ratio of -0.16. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Indivior Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Indivior Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Indivior Pharmaceuticals Inc to industry peers.
Indivior Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Indivior Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Indivior Pharmaceuticals Inc to industry peers.
INDV P/E Ratio Insights
See Indivior Pharmaceuticals Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in INDV
Order type
Buy in
Order amount
Est. shares
0 shares
INDV P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $33.60 | 33.45 |
| Nov 3, 2025 | $31.20 | 31.06 |
| Oct 1, 2025 | $23.46 | 33.10 |
| Sep 2, 2025 | $24.60 | 34.71 |
| Aug 1, 2025 | $21.05 | 29.70 |
| Jul 1, 2025 | $14.66 | -64.44 |
| Jun 2, 2025 | $12.46 | -54.77 |
| May 1, 2025 | $11.55 | -43.63 |
| Apr 1, 2025 | $9.38 | -35.44 |
| Mar 3, 2025 | $9.55 | -36.08 |
| Feb 3, 2025 | $11.73 | -494.94 |
| Jan 2, 2025 | $12.50 | -527.43 |
INDV End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 34.85 | -2.44% |
| 2025 | 35.72 | -106.81% |
| 2024 | -524.47 | +5,792.92% |
| 2023 | -8.90 | -148.34% |
| 2022 | 18.41 | +49.67% |
| 2021 | 12.30 | — |
FAQs About Indivior Pharmaceuticals Inc (INDV) P/E ratio
The latest P/E ratio of INDV is 34.85, as of Feb 2, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Indivior Pharmaceuticals Inc’s last 12-month average P/E ratio is -0.16, compared to its current P/E ratio of 34.85. This reflects a decrease of -21,881.25%.
Indivior Pharmaceuticals Inc’s current P/E ratio of 34.85 is lower than its last 12-month average P/E of -0.16. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Indivior Pharmaceuticals Inc’s average P/E ratio over the last 3 years is 51.19. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Indivior Pharmaceuticals Inc’s average P/E ratio over the last 5 years is 33.92. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.